These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19782074)

  • 1. The brain RAS and Alzheimer's disease.
    Wright JW; Harding JW
    Exp Neurol; 2010 Jun; 223(2):326-33. PubMed ID: 19782074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.
    Wright JW; Harding JW
    J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):226-37. PubMed ID: 19126664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].
    Ohrui T
    Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin and Alzheimer's disease: therapeutic prospects.
    Gard PR; Rusted JM
    Expert Rev Neurother; 2004 Jan; 4(1):87-96. PubMed ID: 15853619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
    Kehoe PG; Wilcock GK
    Lancet Neurol; 2007 Apr; 6(4):373-8. PubMed ID: 17362841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
    Wright JW; Kawas LH; Harding JW
    Prog Neurobiol; 2015 Feb; 125():26-46. PubMed ID: 25455861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
    Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
    Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensins in Alzheimer's disease - friend or foe?
    Kehoe PG; Miners S; Love S
    Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin converting enzyme and Alzheimer's disease].
    Kugaevskaia EV
    Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease.
    Hou DR; Wang Y; Zhou L; Chen K; Tian Y; Song Z; Bao J; Yang QD
    Chin Med J (Engl); 2008 Nov; 121(22):2320-3. PubMed ID: 19080340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.